Eris, Strides Shasun shares gain up to 7 percent on Rs 500 crore deal
New Delhi: Shares of Eris Lifesciences and Strides Shasun rose by as much as 7 percent after both the companies entered into a definitive pact to buy Strides India branded business for Rs 500 crore.
The scrip of Eris Lifesciences surged 6.70 percent to end at Rs 624.30 on BSE. During the day, it zoomed 9 per cent to Rs 637.90.
The stock of Strides Shasun, a Bengaluru-based company, rose 3.81 percent to settle at Rs 817.70. Intra-day, it gained 4.33 percent to Rs 821.85.
Ahmedabad-based drug maker Eris Lifesciences has entered into a definitive pact with Strides to acquire latter's India branded generics business for a cash consideration of Rs 500 crore.
"The transaction is subject to customary closing conditions and parties intend to close the transaction by November 30, 2017," the companies said in a joint statement on Saturday.
Next Story
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd